http://www.frost.com/prod/servlet/svcg.pag/HC00 - Healthcare Research Wed, 8 Feb 2012 16:41:44 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=252839508 Atypical antipsychotics are the most expensive drugs prescribed for bipolar disorder, contributing nearly three-fourth of the revenues of the European bipolar disorder therapeutics market, which was valued at $1.20 billion in 2011. Mon, 6 Feb 2012 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=252840000 Mon, 6 Feb 2012 00:00:00 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-81-00-00 This issue profiles plant-derived protein therapeutics for lowering healthcare costs, a cell-free expression system for scalable production of protein therapeutics, and a drug and vaccine delivery platform based on stomach bacteria. Strategic partnership details and some important patents have also been included. Fri, 3 Feb 2012 05:39:03 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P59A-01-00-00-00 This research service presents an overview of hospital-acquired infections, global scenario, key incidences and trends in Taiwan. The study is segmented based on the type of infections blood stream, respiratory tract, urinary tract and surgical site infections . It provides in-depth geographical analysis of HAI incidence and trends in these countries. Key opinion leaders and infection control heads in Taiwan hospitals were interviewed to obtain their perceptions on the type of infections, strategies, and measures adopted to prevent HAI, understand the challenges faced, and how they plan to use technology in preventing HAI. Fri, 3 Feb 2012 05:39:02 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6F-00-00 This issue profiles a method for improving performance of shell and coil heat exchangers, a drug for treatment of HIV-infected cellular reservoirs, and using robotic catheterization as a dynamic guiding medical technology for cardiovascular procedures. Fri, 3 Feb 2012 05:08:07 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D833-00-CC-00-00 This Future Tech Alert profiles developments in optogenetics, which is an emerging genetic discipline for studying cell function. Fri, 3 Feb 2012 02:21:02 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D785-00-71-00-00 This issue profiles nanomedicine-based on RNA technology, a nanobiotechnology platform for vaccination and drug delivery approaches, and nanocarriers for therapeutic drug delivery applications. Fri, 3 Feb 2012 01:35:03 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M792-01-00-00-00 The Research Service aims to analyse and assess the European market for Multiple Sclerosis. This is performed by analysing the key trends and dynamics shaping the industry sector in co-relation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and new healthcare reforms introduced by governments, the Multiple Sclerosis market employs different trends like shift towards biologics which helps the market grow at a fairly steady pace. This research service provides an in-depth knowledge of the key European markets by presenting significant growth opportunities for the existing and the pipeline drugs with their impacts over market revenue contributed over a period of time. Tue, 31 Jan 2012 11:09:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7C8-01-00-00-00 The aim of this research service is to thoroughly assess and analyse the in vitro diagnostics market in Western European countries and provide strategic recommendations and conclusions for the success of the market participants. This study gives an understanding of the key segments (Immunochemistry, Microbiology, Molecular Diagnostics, POCT, SMBG, Tissue Diagnostics, Hematology and Hemostasis), the likely future trends, revenue forecasts and competitive analysis of the Western European in vitro diagnostics market. This research also involves analysis of IVD market in the United Kingdom, Germany, France, Italy Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Norway, Sweden, and Finland). Mon, 30 Jan 2012 03:58:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7D0-01-00-00-00 Mon, 30 Jan 2012 03:27:33 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P5E8-01-00-00-00 This research deliverable provides deep insights into the clinical development and outsourcing market in India. It also includes an overview of the Indian regulatory and R&D process briefing. It further highlights the key trends, drivers, and restraints of the clinical research market. The research deliverable also covers the forecast of the CRO market from 2008 to 2016. The research service also gives a deeper insight not only into the phase wise as well as therapy wise detail of the clinical trials. Mon, 30 Jan 2012 03:19:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7C2-01-00-00-00 This study analyses the Operating rooms of the future and its prospects in Europe. It presents the market drivers and restraints for growth that are influencing its acceptance and adoption in Europe. It examines the market in terms of industry challenges faced by market participants and also discusses the competitive and technology trends present in the market. A detailed note about on individual countries is presented to explain in detail about the indulgence of this disruptive technology in healthcare delivery in respective countries. Finally, there is a note on the market predictions, and the various success factors and roadmap for implementation that can help in capitalizing on opportunities. Mon, 30 Jan 2012 02:58:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7D9-01-00-00-00 The primary objective of the study European Genetic Testing and Screening Services market is to assess the market potential of the current ongoing testing areas pertaining to the area of genetics such as diagnostic testing, relationship testing and predictive testing. Direct to consumer testing has received an immense attention and is creating the need to regulate the policies standards set for laboratories. Country wise predictions and their growth rates over the period 2010-2018 have been discussed for each segment. European regulations and the existing laws pertaining to genetic testing in the Western European countries have been discussed. A comprehensive list of 90 commercial test providers and manufacturers have been illustrated. Mon, 30 Jan 2012 01:25:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-80-00-00 This issue profiles enhancing microbe detection and identification, a tobacco plant cell-based protein expression platform for biosimilars, and approaching hepatitis C therapies through monocistronic reporter viruses. Strategic partnership details and some important patents have also been included. Fri, 27 Jan 2012 23:12:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=NA6D-01-00-00-00 This research service covers the United States glaucoma pharmaceuticals market from 2008 to 2016, with 2010 as the base year. Included in the study are products on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by classes of drug: prostaglandins, beta-blockers, alpha-adrenerigic agonists, carbonic anhydrase inhibitors, and fixed-dose combinations. Fri, 27 Jan 2012 12:47:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D860-00-5B-00-00 This issue profiles manual axial loaded MRI for patients suffering from spinal instability, T-wave medical scanners for revolutionizing medical imaging, and a non-invasive imaging technique for detecting prognosis of brain tumor. Fri, 27 Jan 2012 05:14:32 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9AB-01-00-00-00 This study covers the North American market for cardiovascular image and information management systems including cardiology picture archiving and communication systems (C-PACS) and cardiovascular information systems (CVIS) by examining drivers and restraints, revenue, units, and pricing forecasts as well as technology trends, procedure volumes, regulatory forces, and customer demand. Market revenue is forecasted across market sub-segments such as the various imaging modalities comprising the cardiovascular care continuum, various customer segments making up the total market, and various solution types presenting distinct market opportunities. The base year is 2010, and forecasts are made until 2017. Wed, 25 Jan 2012 15:01:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N910-01-00-00-00 The scope of this research service primarily includes tissue engineering products and companies in the wound care and surgery space. Surgery includes cardiovascular, orthopedics, neurology, organ regeneration, hernia repair and breast reconstruction. The dynamic market for tissue engineering is growing steadily over the last decade and continues to grow. A thorough understanding of revenue, procedure and demand analysis is provided for different segments of the study. Tissue engineering market is highly competitive, with more than 50 manufacturers selling hundreds of different products. Since this market is a highly evolving space, there is plenty room for smaller entrepreneurial companies to offer innovative products in the market. Mon, 23 Jan 2012 10:47:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D851-00-0A-00-00 This issue profiled a paper-based diagnostic test for influenza, heart monitoring device for tracking sudden cardiac arrest, and device implantation challenges addressed by using bio-based coatings. Fri, 20 Jan 2012 06:40:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7F-00-00 This issue profiles a simultaneous study of chromatin and DNA methylation in a microplate platform, improving cancer diagnostics and therapeutics through epigenetic applications, and plant cell expression-based protein therapeutics. Strategic partnership details and some important patents have also been included. Fri, 20 Jan 2012 02:39:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E5-01-00-00-00 Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies. Risks due to supply and distribution of fake /spurious drugs is also on the rise with many anti -counterfeit solutions being developed. This research service delves into the technology trends in pharmacovigilance and anti-counterfeit technologies and also discusses some of the recent activities and developments from every segment of the industry. Thu, 19 Jan 2012 04:58:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD31-00-01-00-00 Burden of Disease or Conditions Decision Support Database provides information on exhaustive list of Measurements on Incidence, Prevalence and Mortality for different types of Communicable and Non Communicable Disease. Mon, 16 Jan 2012 00:55:34 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-3A-00-00 This issue profiles harnessing cellular senescence pathway for cancer therapeutics, biomarker discovery and drug profiling empowered by label-free phosphoproteomics, and a drug composition as therapeutic/vaccine for obesity and atherosclerosis. Fri, 13 Jan 2012 05:52:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7E-00-00 This issue profiles a microarray platform for orphan receptors and ligands, a ligosachharide-based test for diagnosis and prognosis of MPS, and an antibody generating platform based on somatic hypermutation. Strategic partnership details and some important patents have also been included. Fri, 13 Jan 2012 04:37:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D705-00-6C-00-00 This issue profiles drug delivery systems for regenerative medicine, an electron model for enhancing particle therapy for cancer, and a new sensor technology for detecting deterioration of telecommunication cables. Fri, 13 Jan 2012 01:21:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7D-00-00 This issue profiles an RNA-based expression system for vaccine development, a gene array that aids in diagnosis of anti-EGFR responsive mCRC, and using virus-like particles for counteracting against emerging pathogens. Strategic partnership details and some important patents have also been included. Fri, 6 Jan 2012 03:10:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M75A-01-00-00-00 This research service provides a comprehensive analysis of the European services opportunities market for medical imaging. This research service includes an analysis of the challenges affecting the industry, factors driving and restraining the growth of the market and opportunities that participants can look forward to during the forecast period of 2010 to 2017. The report focuses on the European mobile imaging services, maintenance services and managed equipment services markets. It also provides a brief competitive analysis of all market participants present in the market in the form of a table along with their service portfolio and market coverage. Thu, 5 Jan 2012 09:19:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M737-01-00-00-00 This research service analyses the emerging stem cell therapeutics applications by geographic regions, encompassing Europe - The United Kingdom, Germany, Sweden, Belgium, Finland, France and Spain. The study covers various areas of interest such as regulatory policies within stem cell research, emerging companies, key business updates, analysis of risk factors, and strategic recommendations. Small molecules and biologics like antibodies that aim to stimulate in vivo regenerative action, basic cell culture tools/media suppliers, gene therapy and non-stem cell-based therapy markets are not included in this study. Thu, 5 Jan 2012 00:38:56 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=250608955 Multiple Sclerosis (MS) can be classified as a neurodegenerative, immune-mediated disorder of the central nervous system. The signs of the diseases in most cases are sensory or visual disturbances, weakness in the limbs and symptoms affecting the bladder and bowel. This is followed by either a recovery or an intensification of the symptoms. Fatigue is a symptom, which although not very important medically Thu, 5 Jan 2012 00:00:00 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M59A-01-00-00-00 Spiraling healthcare expenditure threatens to reach unsustainable levels on a global scale, which is driving a shift in investment patterns and healthcare business and delivery models. The focus is on better delivery of healthcare and lower costs. Europe is witnessing a rise in the adoption rate of innovative business models such as SaaS, Managed Services, Open Source, and Freemium. The scope of this short issue-based research service is to provide a strategic analysis of the various business models being implemented in the healthcare information technology sector with focus on SaaS, managed services, open source software and the Freemium business models. Wed, 4 Jan 2012 09:16:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P583-01-00-00-00 This research service presents an analysis of the key hospital indicators in GCC. It forecasts the key healthcare indicators in the GCC countries from 2006 - 2011 This research service provides in-depth analysis of industry challenges, market drivers and market restraints, and how they impact the market dynamics during the forecast period. It provides a forecast of healthcare infrastructure and manpower needs of the GCC countries. The research also gives an outlook about the Growth Trends in Healthcare in the GCC Countries and Investment Opportunities in Healthcare in The GCC Countries. Sat, 31 Dec 2011 03:37:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=P5D0-01-00-00-00 Sat, 31 Dec 2011 01:28:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M791-01-00-00-00 This research study covers some of the key segments of the infectious diseases diagnostics market in western Europe. The main countries in the scope include the UK, France, Germany, Italy and Spain. The infectious disease segments that have been covered include MRSA, TB, HPV and emerging infections such as Hanta Virus and WNV. Wherever applicable, country-wise testing volumes information has been provided. Also revenue forecasts, unit shipments, market share analysis and competitive analysis has been provided. Sat, 31 Dec 2011 01:25:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N8FD-01-00-00-00 The Biologics Market in Brazil is facing a growing stage, being Monoclonal Antibodies the most significant segment. The Brazilian market is moving towards to became a highly regulated market and several patents of blockbusters are about to expire, causing changes in the biologics scenario. This research provides an analysis of Biologics market in Brazil, regarding to Monoclonal Antibodies, Blood Factors, Insulin, Filgrastin, Interferon, Growth Hormone and Erythropoietin. The base year of the study is 2010, and the forecast period is 2011 to 2016. Sat, 31 Dec 2011 01:21:32 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M7A8-01-00-00-00 This research service provides a qualitative analysis of the Critical Care Solutions market in the European region emphasising on the market trends. The rise in aging population and increased occurrence of chronic disorders, cardiovascular diseases and faulty lifestyle across the globe have driven the demand for better equipped healthcare facilities. Trends are discussed for equipment which could be a patient monitor, vital signs monitor or the single or dual parameter monitors used in the critical care environment. The parameters generally monitored include blood pressure, blood glucose , temperature, pulse oxymetery, intra cranial pressure etc. Sat, 31 Dec 2011 01:10:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M741-01-00-00-00 This issue based deliverable has a detailed analysis of the medical imaging industry explaining some of the keys trends and applications within each imaging modality. The modalies covered in this report are magnetic resonance imaging, computed tomography, ultrasound, mammography, C-arms, picture archiving and communication systems, computer aided detection and medical displays. The rport also assesses the impact of various drivers and restraints in each imaging industry. Sat, 31 Dec 2011 01:06:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M729-01-00-00-00 This research service provides an analysis of various aspects of the medical imaging market in Eastern European countries and Russia for the period between 2009 and 2015. The market has been divided into seven segments: general X-ray, MRI, CT, ultrasound, molecular imaging, mammography and PACS. The market has been covered segment wise, as well as geography wise, covering six countries (Bulgaria, the Czech Republic, Hungary, Poland, Romania and Russia). A detailed analysis of the competitive landscape has been presented. The research service highlights main drivers and restraints for the market growth as well as key trends in the medical imaging market for the period from 2011 to 2015. Sat, 31 Dec 2011 00:36:07 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7C-00-00 This issue profiles a fabric-based platform for rapid multiplexed diagnostics, a method for treating sickle cell anemia using patient's own cells, and using recombinant fibrinogen as a therapeutic tool for blood and bone diseases. Strategic partnership details and some important patents have also been included. Fri, 30 Dec 2011 05:57:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2C6-01-00-00-00 The nucleic acid drugs sector consists of three major sub-sectors--aptamer therapeutics, antisense therapeutics, and RNA interference. Recent partnerships and alliances show an amalgamation of collaborations for discovery platforms and delivery technologies as well as drug entities. This report analyzes the R&D portfolio trends in these sub-sectors and then uses the Analytical Hierarchy Process (AHP) to prioritize different options that can be executed to design a strategic R&D portfolio,which showcases a company's innovation capacity and also leads to higher credibility among investors. Portfolio options have been prioritized on a disease basis which is the one commonly followed by both big pharmaceuticals and biotech companies. Fri, 30 Dec 2011 05:57:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D851-00-09-00-00 This issue profiles a biomolecular detection platform for customized research and clinical applications, a surgical adhesive that seals layers of internal tissues and controls fluid accumulation, and molecular diagnostics based on isothermal amplification for POC use. Fri, 30 Dec 2011 03:54:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2DF-01-00-00-00 Harnessing advances in digital pathology techniques, pathologists can now digitize glass slides and perform digital slide interpretations remotely, in many cases eliminating the need to transfer the slides manually.Core users of digital pathology platforms use this technology advance in niche applications and subsequently expand the utility of the system to offer outreaching pathology services and consultations to hospitals worldwide.Promising application segments benefitting from automation by digital pathology solutions includes: toxicology pathology, image analysis, radiology, telepathology, PACS, and tissue microarray. Fri, 30 Dec 2011 02:41:32 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E7-01-00-00-00 Paper-based records have existed for centuries and their gradual replacement by computerised records has been in practice for sometime now in the western countries. Adoption has varied greatly from country to country. Electronic medical records are the centre of focus of any computerised health information system and without them modern technologies such as decision support systems cannot be effectively integrated with routine clinical workflow. This research service therefore highlights market penetration assessment, technology assessment and benchmarking, stakeholder analysis, patent analysis to name a few. Fri, 30 Dec 2011 02:14:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2E4-01-00-00-00 The research service brings out the emerging technology trends in automated microbiology space on a global scale with focus on clinical and pharmaceutical microbiology needs. The report provides impact analysis of major drivers and restraints influencing the adoption of automated microbiology, with a detailed assessment of technology adoption levels and demand side analysis. Further, the report covers emerging opportunity evaluation, AHP based prioritization of techniques for rapid pathogen detection and strategic recommendations along with technology management strategies and roadmap. Finally, a list of key patents provide an insight into notable developmental activities receiving funding along with a database of global participants. Fri, 30 Dec 2011 00:37:48 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-02-00-00 Healthcare Expenditure - Decision Support Database focuses on expenditure status of different countries across regions. This database presents fundamental healthcare indicators that aim to explain the wound management capabilities of nations. Thu, 29 Dec 2011 08:26:37 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD23-00-01-00-00 Healthcare Infrastructure - Decision Support Database focuses on health infrastructure status of different countries across regions. This also has a separate set of parameters pertaining to Health Infrastructure of United States only Thu, 29 Dec 2011 08:25:38 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=DD06-00-01-00-00 Industry - Decision Support Database focuses on the Biotech Market Structure, growth, investments of different countries across regions. Measurement in this Decision Support Database helps to understand the level of activity in the field of biotechnology, also it enables a comparison across geographic regions Thu, 29 Dec 2011 08:25:37 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=D2DD-01-00-00-00 This research service provides a comprehensive overview of the technological advancements in the Stimuli Responsive Polymers. It covers technology capability, technology trends, value-chain analysis, technology adoption cycle, and demand side analysis of the technologies based on Stimuli Responsive Polymers . Further, it focuses on life-cycle analysis, growth opportunity assessment of various technologies in this domain. The study captures industrial and academic innovations of various technologies and products based on Stimuli Responsive Polymers, key drivers and restrains and their impact on different industry verticals. It also provides a list of key patents, key contacts and decision support database tables. Thu, 29 Dec 2011 04:46:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72C-01-00-00-00 This research service provides an analysis of various aspects of the molecular diagnostics market in Europe for the years 2007 - 2015. The market has been divided into four segments: infectious diseases, genetic diseases, oncology and pharmacogenomics. The market has been covered segment wise, as well as geography wise, covering seven countries and regions. A detailed analysis of competitive landscape has been presented. The research service highlights main drivers and restraints for the market growth as well as key trends in the molecular diagnostics market for the period from 2011 to 2015. Wed, 28 Dec 2011 04:40:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M74C-01-00-00-00 The Research Service aims to analyse and assess the European Thrombosis Therapeutics Market, by analysing the key trends and dynamics shaping the industry sector in co-relation with the market drivers and restraints. With several key blockbuster drugs losing patent protection and new Healthcare Reforms introduced by the Governments, the Thrombosis market employs different trends to keep the market growing at a fairly steady phase. This study provides an in depth knowledge of the key European markets by presenting significant growth opportunities for the existing and the pipeline drugs with their impacts over a period of time. Tue, 27 Dec 2011 22:03:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M72F-01-00-00-00 The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research: bio-imaging and microscopy, cell biology tools, immunochemicals, molecular biology tools, and protein biochemistry tools. The study also looks into the usage pattern of these tools. An extensive end-user survey was conducted with 25 laboratories to assess the requirement and usage of tools. Insightful review of key industry drivers, restraints and challenges have been discussed. Leading market players and the prevailing competitive landscape for each of the segments have been discussed. Tue, 27 Dec 2011 07:57:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M722-01-00-00-00 The research service, Analysis of advanced wound management in Western Europe includes revenue forecasts and analysis for total market along with its segments. The main segments covered in this market include; NPWT, moist wound dressings, antimicrobial dressings and active therapies. The forecast and trends are also provided for the geography which includes Germany, UK, France, Italy, Spain, Benelux and Scandinavia. The research service also provides a product portfolio of market participants and also the top competitors profiling. It concludes with the strategic recommendations through the analysis carried out throughout the study. The research service contains the list of key industry participants in the advanced wound management market. Mon, 26 Dec 2011 05:29:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M74E-01-00-00-00 The research service aims to analyse and assess the global generics pharmaceutical market, map the key trends and dynamics shaping the industry sector and provide strategic recommendations for the success of the market participants. With several key blockbuster drugs losing patent protection and new healthcare reforms being introduced by the Governments, the generics pharmaceutical market is on a growing curve. This study provides an in-depth knowledge of the key national markets and therapeutic areas presenting significant growth opportunities for generics, consolidation trends in the industry and impact of regulation on each of the markets. Fri, 23 Dec 2011 22:54:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N4A5-01-00-00-00 This study covers the technology trends and business opportunities of PACS market for Brazil, Argentina and Mexico, examining the characteristics of the product, drivers and restraints for market growth, industry challenges, pricing, technology trends, demand and installed base. Following from these, market sizing in terms of revenues and units are forecasted, including the future growth rates. In addition, an in-depth analysis of the competitive situation including vendors' market shares is performed, along with profiles of the key players in the industry. The base year is 2009 with forecasts running through 2016. Thu, 22 Dec 2011 10:51:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N993-01-00-00-00 The scope of this research service includes market segmentation for synthetic mesh, biologic meshes, and fixation devices used in hernia repair procedures. Analysis includes revenue forecasts, procedure estimates, pricing analysis, and competitive share discussions for all market segments. The base year for the study is 2011 and forecast period is 2012 to 2016. Region of focus is the United States. Hernia repair market has witnessed a surge in activity in the last decade. Materials used in mesh are becoming a major competitive factor. Going forward, the market is expected to grow with technology advancements. Wed, 21 Dec 2011 12:11:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9B6-01-00-00-00 This study covers the U.S. Broadband mHealth Market, examining the drivers and restraints, technology, and demand trends. The total market growth is forecasted. In addition, an in-depth analysis of the convergence of this market with telehealth is provided. The base year is 2010, and forecasts are made until 2015. The study reviews downloadable mobile software application sold through a major app store and web-based software application accessed through a mobile device's Internet browser. The study excludes non-dedicated hardware (e.g. cell phones, smartphones, and tablets). Wed, 21 Dec 2011 11:30:30 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=249413351 Over the past three decades, the Healthy People Initiative has become the nation's barometer for identifying unmet needs for at risk populations, and setting priorities and 10-year performance objectives to improve the health of all Americans. Wed, 21 Dec 2011 00:00:00 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9EF-01-00-00-00 The U.S. anticoagulant market is on the verge of a potential major shift in clinical practice, from a market dominated by a single injectable anticoagulant to a highly competitive market dominated by first-in-class novel oral anticoagulants. While these novel oral agents are expected to become standard of care for stroke prevention in atrial fibrillation patients, injectable agents will likely maintain their hold on certain hospital-based critical care applications. This research service covers the U.S. anticoagulant market from 2008 to 2016, with 2010 as the base year. Included are products on the market, products in development, and patient and revenue forecasts. Market challenges, drivers and restraints are identified and assessed. Tue, 20 Dec 2011 10:35:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N952-01-00-00-00 The editors of Lab Manager Magazine and Frost & Sullivan recently conducted a survey to better understand the sequencing end-user base. A total of 79 Lab Manager Magazine readers qualified for the survey as current or future users of sequencing technology, representing research and clinical laboratories, core facilities, sequencing services providers, and major genomes centers globally. This analysis investigates topics such as current and future adoption of sequencing technologies, brand and instrument preferences, outsourcing, laboratory budgets, sequencing utilization, applications, and challenges. Tue, 20 Dec 2011 10:35:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M770-01-00-00-00 The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market participants. This study is focused on established segments in Europe including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth Hormones and emerging segments including monoclonal antibodies, Insulin and interferon. The established market segments consist of products currently approved and marketed in Europe. New therapeutic classes of drugs are expected to be a major contributor in the emerging market segments. Tue, 20 Dec 2011 09:34:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9CE-01-00-00-00 This research service evaluates the U.S. medical ultrasound imaging systems market over the 2007 to 2015 time period. It provides background information and an overview of the market, specifies important market metrics, identifies key market drivers and restraints, and evaluates ongoing technology trends, market competitors, product offerings and key competitor market shares in 2010. Based on these factors, annual unit shipments, average selling prices, and revenues are estimated and forecasted for product segments of the market, and revenues are estimated and forecasted for clinical segments of the market. Fri, 16 Dec 2011 11:01:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7B-00-00 This issue profiles enhancing translational research in cancer through systems biology approaches, a placenta-derived stem cell therapy for a wide array of applications, and an adenoviral-based gene therapy for hemophilia B. Strategic partnership details and some important patents have also been included. Fri, 16 Dec 2011 06:29:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D950-00-39-00-00 This issue profiles using an anti-telomerase therapy for drug-resistant mature or stem cancer cells, using carbohydrate mimetic peptide as an effective drug delivery vehicle, and using ellipticine compounds as anti-obesity small molecule therapeutics. Fri, 16 Dec 2011 05:28:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D851-00-08-00-00 This issue profiles regenerative solutions offered through process of decellularisation, a technique for enhancing growth of nanosensing arrays, and a cap-like device for reducing catheter-related blood stream infections. Fri, 16 Dec 2011 05:27:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M732-01-00-00-00 This research service was carried out on three countries in East Africa; Kenya, Tanzania and Uganda. The research service focuses on analysing the market opportunity for testing and monitoring of five key diseases in this region; HIV, malaria, TB, HPV and diabetes. A brief healthcare overview of each country is provided in the research. Additionally, the research also provides an overview of laboratory services in each of the three countries. A seven-year forecast of the opportunity in the market for testing and monitoring the highlighted key diseases is also provided in the research service. Fri, 16 Dec 2011 02:42:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M781-01-00-00-00 This research service aims to provide a detailed analysis of the PACS market in East European nations, focusing on Bulgaria, Czech Republic, Hungary, Poland and Romania. This research service includes a brief overview of PACS, its benefits, analysis of the challenges affecting the industry, factors driving and restraining the growth of the market and opportunities that participants can look forward to during the forecast period. The main objectives of this study are to provide an understanding of market opportunities, market size and forecast assessment. The various sales models observed in this region are also described in this study. Thu, 15 Dec 2011 22:53:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=M78C-01-00-00-00 The Research Service offers analysis and assessment of the European Pharmaceutical and Biotech Contract Manufacturing Markets, maps the key trends and dynamics shaping the industry sector, and provides strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the Pharmaceutical Contract Manufacturing Market in terms of Solids, Liquids, and Injectables finished dose formulations; and the Biotech Contract Manufacturing Market, in terms of Mammalian and Microbial cell culture based products, with a specific focus on the key five countries in Europe - Germany, France, the United Kingdom, Italy, and Spain. Thu, 15 Dec 2011 22:38:30 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=248901213 Thu, 15 Dec 2011 00:00:00 +0000 http://www.frost.com/prod/servlet/market-insight-top.pag?Src=RSS&docid=248855498 The dawn of health enabled vehicles is giving new meaning to the term 'mobile aid devices'. Ford Motor Company recently created some buzz with its announcement of a prototype for health enabled capabilities integrated with its Synch telematics platform. The profiled prototype requires integrated expertise from the automotive, medical device, and telehealth fields. While a ground breaking achievement on its own, the promising future developments this platform could lead to has many in the industry intrigued. Wed, 14 Dec 2011 00:00:00 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N967-01-00-00-00 Professional usage of social media (both individual and within institutional frames) is high within healthcare providers institutions. However, only a minority of provider institutions have a dedicated budget for social media. The majority of employees have access to social media in their workplace, but the majority of provider institutions using social media employ some access policies for employee use. Social networking and institutional social media are most often used (among other media), both individually for professional use and for institutional use. Provider institutions appear most interested in using social media for marketing purposes. Social networking and institutions' own social media best fulfill institutions' needs. Mon, 12 Dec 2011 11:21:31 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D785-00-6A-00-00 This issue profiles using nanotechnology for making patient-compatible implants, nanotechnology-based device for point-of-care hemorrahic fever diagnosis, and a graphene-based transistor array in bioelectronic applications. Fri, 9 Dec 2011 06:13:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D755-00-7A-00-00 This issue profiles applying quartz crystal microbalance for small pox virus detection, an antibody-based gene therapy for HIV infections, diagnostic kits using blood samples and biomarker testing for early disease detection. Strategic partnership details and some important patents have also been included. Fri, 9 Dec 2011 03:57:30 +0000 http://www.frost.com/prod/servlet/segment-toc.pag?Src=RSS&segid=D860-00-5A-00-00 This issue profiles an enhanced anterior segment sOCT system, mobile C-arm with imaging features comparable to fixed systems, and a non-invasive skin cancer detection device. Fri, 9 Dec 2011 03:26:30 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=N9D8-01-00-00-00 This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that can treat localized tumors. SRS systems, due to their accuracy and precision, minimize damage to healthy tissue, making them ideal for treatment of complicated tumors located near the brain or spine. This survey is intended to gather qualitative feedback on how radiosurgery centers plan to work around external challenges. Thu, 8 Dec 2011 07:59:31 +0000 http://www.frost.com/prod/servlet/report-toc.pag?Src=RSS&repid=NA7B-01-00-00-00 The U.S. biosimilars market is a fast approaching reality. However, much uncertainty lies ahead, including the market potential as a function of physician adoption of biosimilars. This panel discussion was conducted to preview the thoughts and expectations of specialty physicians who would be expected to be among the first customers of biosimilars, with the objective of gaining insight into some of the major factors which could influence market uptake. The research for this service was gathered from a panel consisting of 20 pre-selected specialty physicians and was conducted via online moderated discussion boards over a three-day period. Key findings, qualitative analyses and recommendations are included. Thu, 8 Dec 2011 07:44:31 +0000